A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

February 28, 2001

Primary Completion Date

April 30, 2004

Study Completion Date

April 30, 2004

Conditions
Carcinoma, Non-small-cell Lung
Interventions
DRUG

Epothilone

Trial Locations (16)

21201

University of Maryland Greenbaum Cancer Center, Baltimore

27599

Unviversity of North Carolina, Chapel Hill

33140

Mount Sinai Medical Center, Miami Beach

33612

H Lee Moffitt Cancer Center, Tampa

35294

University of Alabama at Birmingham, Birmingham

37203

Sarah Cannon Cancer Center, Nashville

40207

Consultants in Blood Disorders, Louisville

53792

University of Wisconsin Hospital, Madison

65203

University of Missouri/Ellis Fischel Cancer Center, Columbia

70121

Ochsner Cancer Institute, New Orleans

958177

Un of California Davis Cancer Center, Sacramento

60612-3828

Rush Presbyterian St Lukes ME, Chicago

01805

Lahey Clinic, Burlington

03756

Dartmouth-Hitchcock /Norris Cotton Cancer Center, Lebanon

08901

Cancer Institute of New Jersey, New Brunswick

37232-5536

Vanderbilt University Med School Div of Medical Oncology, Nashville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

R-Pharm

INDUSTRY